Lars König

University Hospital, LMU Munich

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Matthias Justus Nikolaus Seifert

National Cancer Institute

UNITED STATES

View details

Carina C. de Oliveira Mann

GERMANY

View details

Sebastian Kobold

University Hospital

GERMANY

View details

Angelika Eisele-Metzger

University Medical Center Freiburg

GERMANY

View details

Johannes Raedler

GERMANY

View details

Steffen Ormanns

LMU (Ludwig Maximilian University)

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lars König

Research Interests

Explore related searches

Contact this professor

Articles (10)

OAS1/RNase L executes RIG-I ligand–dependent tumor cell apoptosis

Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiency

T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours

Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent Manner

Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model

A Novel Complete Autosomal-Recessive STAT1 LOF Variant Causes Immunodeficiency with Hemophagocytic Lymphohistiocytosis–Like Hyperinflammation

Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19

Metabolic implication of tigecycline as an efficacious second‐line treatment for sorafenib‐resistant hepatocellular carcinoma

Tousled-Like Kinases Suppress Innate Immune Signaling Triggered by Alternative Lengthening of Telomeres

RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade

Collaborators (6)

Matthias Justus Nikolaus Seifert

Carina C. de Oliveira Mann

Sebastian Kobold

Angelika Eisele-Metzger

Johannes Raedler

Steffen Ormanns

Make your next move.